Cocoa consumption dose-dependently improves flow-mediated dilation and arterial stiffness decreasing blood pressure in healthy individuals

Journal of Hypertension

Volumn 33, Issue 2, 2015, Pages 294-303

  Grassi, Davide ^a   Desideri, Giovambattista ^a   Necozione, Stefano ^a   Di Giosia, Paolo ^a   Barnabei, Remo ^a   Allegaert, Leen ^b   Bernaert, Herwig ^b   Ferri, Claudio ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Barry Callebaut   (Belgium)

Author keywords

arterial function; blood pressure; cocoa; endothelial function; flavonoids

Indexed keywords

ENDOTHELIN 1; FLAVONOID; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; PLANT MEDICINAL PRODUCT;

ADULT; ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD VESSEL PARAMETERS; CACAO; CALORIC INTAKE; CARDIOVASCULAR EFFECT; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIASTOLIC BLOOD PRESSURE; DIETARY INTAKE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FLOW MEDIATED DILATION; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PULSE WAVE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; VASCULITIS; BLOOD; CHEMISTRY; DRUG EFFECTS; MIDDLE AGED; PHYTOTHERAPY; VASCULAR ENDOTHELIUM;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; CACAO; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FLAVONOIDS; HEALTHY VOLUNTEERS; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; PHYTOTHERAPY; PLANT PREPARATIONS; PULSE WAVE ANALYSIS; VASCULAR STIFFNESS;

EID: 84920935054     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000412     Document Type: Article

References (49)

1. Rimm EB, Ascherio A, Giovannucci E, Spiegelman D, Stampfer MJ, Willett WC. Vegetable, fruit, and cereal fiber intake and risk of coronary heart disease among men. JAMA 1996; 275:447-451.
2. Bendinelli B, Masala G, Saieva C, Salvini S, Calonico C, Sacerdote C, et al. Fruit, vegetables, and olive oil and risk of coronary heart disease in Italian women: the EPICOR Study. Am J Clin Nutr 2011; 93:275-283.
3. Scalbert A, Manach C, Morand C, Remesy C, Jimenez L. Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 2005; 45:287-306.
4. Ferri C, Grassi D. Antioxidants and beneficial microvascular effects. Is this the remedy? Hypertension 2010; 55:1310-1311.
5. Grassi D, Desideri G, Ferri C. Flavonoids: antioxidants against atherosclerosis. Nutrients 2010; 2:889-902.
6. Visioli F, Bernaert H, Corti R, Ferri C, Heptinstall S, Molinari E, et al. Chocolate, lifestyle, and health. Crit Rev Food Sci Nutr 2009; 49:299-312.
7. Grassi D, Desideri G, Croce G, Tiberti S, Aggio A, Ferri C. Flavonoids, vascular function and cardiovascular protection. Curr Pharm Des 2009; 15:1072-1084.
8. Grassi D, Desideri G, Ferri C. Blood pressure and cardiovascular risk: what about cocoa and chocolate? Arch Biochem Biophys 2010; 501:112-115.
9. Grassi D, Lippi C, Necozione S, Desideri G, Ferri C. Short-term administration of dark chocolate is followed by a significant increase in insulin sensitivity and a decrease in blood pressure in healthy persons. Am J Clin Nutr 2005; 81:611-614.
10. Grassi D, Desideri G, Necozione S, Lippi C, Casale R, Properzi G, et al. Blood pressure is reduced and insulin sensitivity increased in glucoseintolerant, hypertensive subjects after 15 days of consuming highpolyphenol dark chocolate. J Nutr 2008; 138:1671-1676.
11. Grassi D, Necozione S, Lippi C, Croce G, Valeri L, Pasqualetti P, et al. Cocoa reduces blood pressure and insulin resistance and improves endothelium-dependent vasodilation in hypertensives. Hypertension 2005; 46:398-405.
12. Hooper L, Kroon PA, Rimm EB, Cohn JS, Harvey I, Le Cornu KA, et al. Flavonoids, flavonoid-rich foods, and cardiovascular risk: a metaanalysis of randomized controlled trials. Am J Clin Nutr 2008; 88:38-50.
13. Desch S, Kobler D, Schmidt J, Sonnabend M, Adams V, Sareban M, et al. Low vs. higher-dose dark chocolate and blood pressure in cardiovascular high-risk patients. Am J Hypertens 2010; 23:694-700.
14. Desch S, Schmidt J, Kobler D, Sonnabend M, Eitel I, Sareban M, et al. Effect of cocoa products on blood pressure: systematic review and meta-analysis. Am J Hypertens 2010; 23:97-103.
15. Ried K, Sullivan T, Fakler P, Frank OR, Stocks NP. Does chocolate reduce blood pressure? A meta-analysis. BMC Med 2010; 8:39.
16. Egan BM, Laken MA, Donovan JL, Woolson RF. Does dark chocolate have a role in the prevention and management of hypertension? Commentary on the evidence. Hypertension 2010; 55:1289-1295.
17. Faita F, Masi S, Loukogeorgakis S, Gemignani V, Okorie M, Bianchini E, et al. Comparison of two automatic methods for the assessment of brachial artery flow-mediated dilation. J Hypertens 2011; 29:85-90.
18. Gemignani V, Bianchini E, Faita F, Giannarelli C, Plantinga Y, Ghiadoni L, Demi M. Ultrasound measurement of the brachial artery flowmediated dilation without ECG gating. Ultrasound Med Biol 2008; 34:385-391.
19. Gemignani V, Faita F, Ghiadoni L, Poggianti E, Demi M. A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging 2007; 26:393-404.
20. Laurent S, Cockcroft J, Van Bortel L, Boutouyrie P, Giannattasio C, Hayoz D, et al., European Network for Noninvasive Investigation of Large Arteries. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006; 27:2588-2605.
21. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2004; 27:S5-S10.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28:412-419.
23. Buijsse B, Feskens EJ, Kok FJ, Kromhout D. Cocoa intake, blood pressure, and cardiovascular mortality: the Zutphen Elderly Study. Arch Intern Med 2006; 166:411-417.
24. Ferri C, Grassi G. Mediterranean diet, cocoa and cardiovascular disease: a sweeter life, a longer life, or both? J Hypertens 2003; 21:2231-2234.
25. Ferri C, Grassi D, Grassi G. Cocoa beans, endothelial function and aging: an unexpected friendship? J Hypertens 2006; 24:1471-1474.
26. Wilkinson IB, Qasem A, McEniery CM, Webb DJ, Avolio AP, Cockcroft JR. Nitric oxide regulates local arterial distensibility in vivo. Circulation 2002; 105:213-217.
27. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: testing and clinical relevance. Circulation 2007; 115:1285-1295.
28. Grassi D, Desideri G, Ferri C. Cardiovascular risk and endothelial dysfunction: the preferential route for atherosclerosis. Curr Pharm Biotechnol Curr Pharm Biotechnol 2011; 12:1343-1353.
29. Schiffrin EL. Canadian institutes of health research multidisciplinary research group on hypertension. Beyond blood pressure: the endothelium and atherosclerosis progression. Am J Hypertens 2002; 15:115S-122S.
30. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction: a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol 2003; 23:168-175.
31. Desideri G, Ferri C. Endothelial activation. Sliding door to atherosclerosis. Curr Pharm Des 2005; 11:2163-2175.
32. Schulman IH, Zhou MS, Raij L. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension. J Hypertens Suppl 2006; 24:S45-S50.
33. Halcox JP, Schenke WH, Zalos G, Mincemoyer R, Prasad A, Waclawiw MA, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002; 106:653-658.
34. Schachinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction and adverse long-term outcome of coronary heart disease. Circulation 2000; 101:1899-1906.
35. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Mu?nzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation 2001; 104:2673-2678.
36. Shrime MG, Bauer SR, McDonald AC, Chowdhury NH, Coltart CE, Ding EL. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr 2011; 141:1982-1988.
37. Safar ME, Levy BI, Struijker-Boudier H. Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases. Circulation 2003; 107:2864-2869.
38. O'Rourke MF, Hashimoto J. Mechanical factors in arterial aging: a clinical perspective. J Am Coll Cardiol 2007; 50:1-13.
39. Zieman SJ, Melenovsky V, Kass DA. Mechanisms, pathophysiology, and therapy of arterial stiffness. Arterioscler Thromb Vasc Biol 2005; 25:932-943.
40. Vlachopoulos CV, Alexopoulos NA, Aznaouridis KA, Ioakeimidis NC, Dima IA, Dagre A, et al. Relation of habitual cocoa consumption to aortic stiffness and wave reflections, and to central hemodynamics in healthy individuals. Am J Cardiol 2007; 99:1473-1475.
41. Taubert D, Roesen R, Lehmann C, Jung N, Schömig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA 2007; 298:49-60.
42. Davison K, Berry NM, Misan G, Coates AM, Buckley JD, Howe PR. Dose-related effects of flavanol-rich cocoa on blood pressure. J Hum Hypertens 2010; 24:568-576.
43. Berry NM, Davison K, Coates AM, Buckley JD, Howe PR. Impact of cocoa flavanol consumption on blood pressure responsiveness to exercise. Br J Nutr 2010; 103:1480-1484.
44. Whelton PK, He J, Appel LJ, Cutler JA, Havas S, Kotchen TA, et al., National High Blood Pressure Education Program Coordinating Committee. Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 2002; 288:1882-1888.
45. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE. Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002; 39:105-110.
46. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al., ESH-ESC Task Force on the Management of Arterial Hypertension. 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2007; 25:1105-1187.
47. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al., Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on Prevention, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
48. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr 2012; 95:740-751.
49. European Food Safety Authority (EFSA). Scientific Opinion on the substantiation of a health claim related to cocoa flavanols and maintenance of normal endothelium-dependent vasodilation pursuant to Article 13(5) of Regulation (EC) No 1924/20061. EFSA J 2012; 10:2809.